Previous studies have demonstrated that CDK2AP1 influence tumor growth such as glioma, lung cancer and esophageal squamous cell carcinoma (Hiyoshi et al., 2009; Sun et al., 2013; Xu et al., 2014). Here, CDK2AP1 is linked to central nervous system cancer.